IMR Press / FBE / Volume 13 / Issue 1 / DOI: 10.2741/871
Open Access Review
Animal models for research on endometriosis
Show Less
1 Department of Obstetrics and Gynecology, Tottori University Faculty of Medicine, Yonago, 683-8504, Japan
Front. Biosci. (Elite Ed) 2021 , 13(1), 37–53;
Published: 1 October 2020
(This article belongs to the Special Issue Frontiers in endometriosis)

Endometriosis results from the aberrant growth of endometrium outside the inner lining of the uterine cavity. Similar to humans, the primates also menstruate and hence, the primate models constitute the gold standard for studying the pathogenesis and potential treatment for this disabling disease in women. Due to the expense in carrying endometriosis research in primates, other models have been developed for understanding the pathobiology and potential treatment of endometriosis. This includes explanting human endometrial tissues in athymic nude mice or using homologous mouse models. Here, we examine the murine models of endometriosis, the impact of forced induced inflammation on its development, similarities in the gene expression profile in the endometriotic tissues in such models with that seen in human endometriosis, and the drugs that are being used in such models as potential new treatment for endometriosis

Murine Endometriosis-Like Lesion
Experimental Model
Cystic Lesion

The exact cause of endometriosis is not certain. However, the most commonly accepted explanation is the Sampson hypothesis which suggested viable endometrial tissue flows retrogradely through the fallopian tube and into the peritoneal cavity where it can attach to and invade tissues and organs within the cavity, all of which occured in a process called retrograde menstruation (1). At least 90% of women experience retrograde menstruation, but endometriosis occurs in only 10% to 14% of women under reproductive age, suggesting that additional factors impact its etiology (2). Based on the implantation theory, we generated the homologous murine endometriosis models by transplanting uterine tissue to mimic the pelvic environment in human endometriosis and analyzed the efficacy of several drugs (Figure 1, Table 1).

Figure 1

A cascade of animal endometriosis mice model. Endometriosis animal model is divided into 2 groups without and those with cyclical menstruation.

Table 1 Representatives of murine endometriosis models
Drug Characteristics of models Reference
Mouse is both the donor and the host
Not tested for drug development Syngeneic GFP transgenic mice, retrograde menstruation model 78
Not tested for drug development Deep endometriosis mouse model 13
Not tested for drug development Laparoscopic mouse model 33
Not tested for drug development P-selectin KO, GFP transgenic mice 18
Not tested for drug development GFP mice 19
Not tested for drug development Adhesion scoring system 79
Not tested for drug development Estrogen receptor KO 40
Not tested for drug development SRC-1 KO 58
Omega-3 polyunsaturated Fatty acids (3-PUFA) Transgenic Fat-1 mice (high levels of endogenous 3-PUFA) 42
Parthenolide Large cyst formation 30
Retinoic acid GFP mice 59
Temsirolimus Deep infiltrating implants 74
Tricostatin A Auto-transplant model 65
Bazedoxifene No description available 31
Celecoxib, Rosiglitazone No description available 75
Leptin receptor antagonist No description available 39
Resveratol No description available 70
Statins No description available 73
Symvastatin No description available 9
Vitamin D receptor Agonist No description available 72
Human is the donor and mouse is the host
ENMD-1068, a protease-activated receptor 2 antagonist Noninvasive fluorescent mouse model 77
Pentoxifylline No description available 76
Cabergoline Assessment nerve fibers 71
M: mouse; H: human, NM: nude mouse, KO: knock out mouse, GFP: green fluorescent protein

Current medical therapeutic agents such as GnRH agonist, progestins, and androgen supplements are used to decrease the ovarian estrogen production and counteract estrogen effects as this hormone initiates endometriosis (3). However, these therapeutic agents have undesirable side effects that limit their long-term use (2). Likewise, the scope of surgical treatment is also limited by a high recurrence rate, which may eventually lead to extreme measures, such as removal of the uterus and ovaries. Today, as science advances, new potential source of drugs from natural resources—for example plants, which may provide less toxicity and side effects—are explored. Thus, animal models to elucidate the mechanisms of endometriosis and develop therapeutic agents to prevent the progression of the disease are very important.

Animal models, which are used in the early stages of drug development, usually rely on non-menstruating models with the induced endometriosis-like lesions. One of the major limitations in endometriosis research is the paucity of robust animal disease models. Ideally, a disease models should mimic human disease and allow scientific investigation of the effects of both intrinsic factors, such as genes, and extrinsic factors, such as environmental factors on disease progression (4).

Several animal models of endometriosis have been established, most of which consisted of transplantation of endometrium into the peritoneal cavity, which is by far the most common site of the disease. Besides rodents, primates such as monkeys that spontaneously develop endometriosis or that have been intraperitoneally transplanted with endometrium can be used as a good animal model for the development and optimization of drug candidates. As monkeys developed endometriosis spontaneously due to cyclic menstrual periods—this model is undoubtedly the most reliable one (4-16). However, laborious requirements for the maintenance of these primate animal models have inhibited the progression of potential drug developments. This being said, most researchers concentrated their studies on smaller mammalian models, such as rats and rabbit (17-22). Moreover, the murine model was considered as a possible candidate for this purpose, and it may provide advantages in terms of new therapeutic approaches (17,18,20,23-29). In recent decades, many knockout or transgenic mice have been generated. The availability of an endometriosis models in mice is crucial because it can be used to investigate some aspects of endometriosis.


Endometriosis is an estrogen-dependent disease. Thus, estrogen receptors play a significant role in the development of the disease. Moreover, among estrogen receptors, Estrogen receptor β (ERβ) showed an association with endometriosis progression. Han et al. used mouse models to observe the role of ER β in the development of endometriosis (54). This is based on the study of Burns et al. where they concluded that the expression of ERβ was required for endometriosis-like lesion in mice (42). This being said, the study used an ERBOE (ERβ over-expressed) mouse to determine the histologic and immunologic change effects of ERβ. Remarkably, they were able to elucidate that over-expression of ERβ can lead to downregulation of immune response such as Interferons, NF-κB, and other inflammatory response. Note that Interferon also plays a significant role in pregnancy, such as in embryo implantation (55) and NF-κB expression regulates the gene expression profiles for implantation and successful pregnancy (56-59). Notably, NF-κB in mouse plays an important role as its activation promotes implantation of the mouse uterus (60,61). Therefore, downregulation of NF-κB signaling by ERβ can contribute to endometriosis in women by impairing embryo implantation.

The successful utilization of mouse models to observe the effects of ERβ in the development of endometriosis open ERβ over-expressed biomarker for endometriosis. This mouse models also provides ERβ explored ER insights on the better understanding of complex molecular etiology of endometriosis induced by estrogen/ ERβ axis (62,63). Moreover, the availability of female mice (C57BL/6J) and its ease in animal laboratory handling provide a great advantage compared to other animal models.


Mice are the most commonly used animal models capable of investigating the pathophysiology of endometriosis. However, they do not spontaneously develop endometriosis. In order to induce endometriosis in mice, endometrial tissue must be transplanted into the peritoneal cavity using methods (10-13), which can be classified into two basic types, homologous and heterologous. Both models produce comparable phenotypes, which are then morphometrically evaluated.

4.1. Homologous or autologous models

In homologous or autologous models, endometrial tissue is transplanted into the peritoneal cavity of recipient mice and starts to grow in an estrogen-dependent manner. In almost all models, uterine endometrial fragments from a donor mouse are directly introduced via injection some by suturing (19,30-32) or inserted laparoscopically (33,34) into the peritoneal cavity of recipient mice. Our studies used a homologous mouse models of endometriosis.(47,48,53).

Care and treatment. According to the implantation theory, we made the readily available murine models which evaluate the development of endometriosis-like lesions (30). Female mice (6 weeks of age, BALB/c) were purchased. Before initiating the experiments, animals were allowed to acclimate to the following conditions for seven days. The mice were put in a controlled temperature range (72–74) on a 12-hour light, 12-hour dark cycle. They were given food and water ad libitum. Recipient mice were ovariectomized through two 0.5-cm dorsolateral skin incisions and were then divided into two treatment groups; estradiol valerate (0.5 μg/mouse·wk) in corn oil or only corn oil vehicle. The mice were dosed subcutaneously once per week for two weeks before they were induced experimental endometriosis. The donor uterus was removed en bloc after euthanasia, cleaned of excess tissue, and washed thrice in sterile phosphate-buffered saline (PBS). The uterus was slit with a linear incision longitudinally and minced (≤1.5 mm). Recipient mice were anesthetized using isoflurane/oxygen and given buprenorphine (0.1 mg/kg) for pain management. A 0.5-cm right dorsolateral incision was made, minced donor tissue (1:2 donor uterus to host ratio) in 500 μl PBS was injected into the peritoneal cavity of the recipient, and was gently massaged to disperse the tissue. An equivalent amount (~100 mg) of minced tissue was transferred into all recipients. The mice were treated for four additional weeks with estradiol valerate (E2) or the vehicle. After four weeks, the mice were euthanized with CO2, their peritoneal cavity was opened, and the endometriosis-like lesions were removed. To assess the effects of drug candidates on ectopic uterine tissue, ectopic lesions were photographed to document in situ endometriosis-like lesions. Endometriosis-like lesions were visualized, dissected, measured, and weighed. Endometriosis-like lesions were removed and were either fixed in 10% formalin or snap-frozen on dry ice and stored at −80 C until use.

In chapter six, we will describe the efficacy of SR-16234 (SR), a selective estrogen receptor modulator (SERM), parthenolide and BV6, an inhibitor of apoptosis protein inhibitor (IAP) on the murine endometriosis-like lesions by using homologous mouse models.

4.2. Heterologous models

In heterologous models, human endometriotic lesions are transplanted into the peritoneal cavity of immune-deficient mice (35,36), and into the peritoneum of immunocompromised mice (37,38). The xenotransplantation models in the nude mouse is also used but is limited by the lack of a normal immune system. Despite the advantage of being based on human endometrial tissues, the number of endometriotic lesions developed in the heterologous models varies from one animal to another. In both models, with or without suturing the endometrial implant, the drug’s influence on the growth of endometrial or endometriotic transplants is evaluated.

However, these established endometriosis models in mice are under discussion. Indeed, mice lack a menstrual cycle and do not develop spontaneous endometriosis. It should be reviewed whether transplanting normal endometrium into the peritoneal cavity of a non-menstruating species reflects all pathophysiological aspects of human endometriosis.

4.3. Knockout and transgenic murine models

The knockout and transgenic murine models provide a suitable environment to study biological factors such as the role of immune system and hormone balance that may affect endometriosis, which cause unbearable pain and possible infertility. These models also enable the evaluation of molecular mechanisms that are critical for disease initiation (39-42). With the existing limitation, additional and ideal models of endometriosis are needed. In the next section, we demonstrate the results using murine endometriosis model that expanded the capability of conducting both mechanistic and translational research.

4.4. Development of an experimental model of endometriosis using mice that ubiquitously express green fluorescent protein

The search for the most suitable candidate animal models to elucidate the disease mechanisms of endometriosis is still under rigorous evaluation. Although the use of small animals such as rabbit, rat, and mouse were a few of the animal models that are intensively studied, several disadvantages such as lesions sometimes being too unclear to be distinguished from surrounding normal tissues is still an issue to be addressed. This indistinctness makes it difficult to determine the weight of the lesions, which is essential in endometriosis studies. To address this issue, a transgenic mouse was developed. The use of green fluorescent protein (GFP) imaging of tumor growth, metastasis, and angiogenesis in mouse models have provided the new insights into the real-time growth and metastatic behavior of cancer. This study inspired the use of GFP imaging in the evaluation of endometriosis progression in mice. Moreover, the sensitivity of the method eliminates the surrounding normal tissues to metastatic tissue, thus making this transgenic mouse models can be a good candidate for the evaluation of endometriosis. In addition, this effort utilized the technology to quantitatively assess the human endometriotic tissue maintenance and regression in a non-invasive mouse model of endometriosis (54). Notably, they were able to demonstrate the feasibility of visualizing fluorescent endometriosis-like lesions in nude mice in a non-invasive manner.

With these scientific efforts, Hirata et al. developed the transgenic mice that ubiquitously express GFP for the evaluation of endometriosis (19). In their study, they provided several advantages of using this animal models; first, its sensitivity. Small endometriotic lesions are often more difficult to be identified by macroscopic examination. However, with the use of GFP-emitted light in the transgenic mice which can be easily detected in dark field, the location of the lesions can easily be discovered. In addition, the level of fluorescence of endometriotic lesions can be used for semi-quantitation of their size. The fluorescence intensity is positively correlated with weight of the lesions. And lastly, this animal models can clearly identify endometriotic cells originating from donor mice in histologic sections. The precise discrimination of endometriotic cells from other cells may have significant implications for the analysis of endometriotic tissues in animal models. However, a great disadvantage of using this model in drug development evaluation is that the GFP interactions to drugs might interfere with the study. Thus, additional evaluation should be conducted to provide a reliable animal model for drug assessment in endometriosis. Nevertheless, this transgenic mouse models can be utilized for the observation of endometriosis development and progression of disease.

4.5. Lipopolysaccharide (LPS)-induced pelvic inflammation

Local inflammatory reaction in the peritoneal environment is also considered one of the contributing factors in the pathogenesis of endometriosis (44). Studies have demonstrated the effects of inflammatory mediators, such as LPS, or combined effects of E2 and LPS on promoting proinflammatory response in pelvis and growth of endometriosis (45,46). As mice with natural estrous cycle were used to be the innate hormonal environment in juvenile mice, in one study, we also analyzed the influence of LPS-induced inflammation using both recipient and donor mice with natural estrous cycle to avoid excess estrogen environment (47). For four weeks, recipient mice were treated with a single intraperitoneal (i.p) injection of LPS (2mg/kg) or vehicle (saline) twice weekly. We demonstrated that administrating LPS for four weeks significantly increased the total number (LPS: 2.8±0.27 vs. vehicle: 1.6±0.22/mouse), the average weight (65.0±9.7 vs. 30.0±5.2 mg/mouse), and the surface area (11.7±2.3 vs. 4.6±0.6 mm2/mouse) of endometriosis-like lesions compared with the vehicle group. LPS enhanced mRNA expression of Ptgs-2, Vegf, Ccl-2, and Il-6 in endometriosis-like lesions. LPS also increased the percentage of Ki67-positive cells and enhanced the intensity and rate of positive cells of CD3, F4/80, and PECAM. Intense expression of phosphor-p65 NF- κB (nuclear factor -kappa B) after LPS administration was observed.


Primate models would be the best fit for experimentation, however, the cost and lack of housing facilities provide great disadvantage to the progress of study of endometriosis. As an alternative model system, mice are readily available and comparatively inexpensive, but the relatedness to human endometriosis is an issue to consider for using them as a good animal models for endometriosis. With this, Pelch et al. investigated the gene expression profile of mouse models compared to women (32). Remarkably, the result showed that mouse endometriotic lesions resemble lesions in women. Moreover, the work has shown that mouse and human endometriotic tissue progresses from a move to a less biologically active form. In addition, the genes thought to be particularly important to endometriosis were altered in the same directions in both the human study and the use of mouse model study. With the remarkable findings of the study that the gene expression profile in the mouse endometriotic lesion is analogous to women, this makes mouse models a good candidate tool for studying endometriosis pathogenesis, pathophysiology, and treatment.

6.1. The efficacy of SR-16234 (SR), a selective estrogen receptor modulator (SERM)

In addition to typical estrogen suppressing agents, combined targeting of E2 and LPS could be useful in the treatment of endometriosis. SR is a SERM, which is reported to have estrogen receptor (ER) α antagonistic activity with a weak partial agonist activity to ERβ (47). SERMs have been considered for using in the treatment of endometriosis due to their antiproliferative effects on the endometrium. Compared to other SERMs, which have ERα partial agonistic activity, SR is predicted to yield a superior effect in humans due to its pure antagonistic action on ERα. We investigated the effects of SR on the development of murine endometriosis-like lesions (48) by establishing the endometriosis models as previously described (30). Considering the synergistic effect between E2 and LPS, we also used the LPS to promote the pelvic inflammatory process. After induction, recipient mice were treated with vehicle or LPS (0.05 mg/kg, i.p; twice a week) without SR or with SR (1mg/kg; subcutaneously, daily). We demonstrated that after 4 weeks of treatment, SR effectively suppressed the growth and inflammatory-associated genes expression in endometriosis-like lesions without inducing endometrial growth (48).

6.2. Effects of parthenolide on the murine endometriosis-like lesions

We undertook a study of fever as a potential therapy for endometriosis that illustrated the effectiveness of the murine models. The medical herb feverfew has long been used as a folk medicine for treating fevers, migraine, rheumatoid arthritis, and dysmenorrhea. Parthenolide is considered the primary bioactive compound in feverfew having anti-tumor and anti-inflammatory properties (49). Parthenolide produces anti-tumorigenesis effects against human acute myeloid leukemia and solid tumors, such as breast and pancreatic cancer (43,50,51). We, therefore, used an experimental mouse models to evaluate the effect of parthenolide as a therapy for endometriosis (30).

We established the models by injecting tissue suspension intraperitoneally. Endometriosis-like lesions had grown in the abdominal cavity of all mice. The deposits appeared as cystic lesions bulging under the serosal coat. Most of the lesions were observed around the abdominal incision, the intestinal membrane, and the renal capsule. The size of lesions ranged from approximately 2 to 8 mm in diameter. Histologic sections stained with hematoxylin and eosin were endometriotic in character. The monolayer epithelial cell lining of the cyst was revealed by hematoxylin and eosin staining.30 We confirmed that cytokeratin (a marker of epithelial cells) and vimentin (a marker of stromal cells) in the mouse endometriosis-like lesions were positive, whereas calretinin (that of mesothelium cells) was negative, indicating that these cystic lesions originated from the injected endometrial tissues, not the peritoneal cells.

In view of the above considerations, we proposed a hypothesis that parthenolide may have an inhibitory effect on the development of endometriosis. After parthenolide treatment for 4 weeks, the total number of lesions (5.8 vs. 3.9/mouse) was significantly reduced, and the average weight (65.6 vs. 29.6 mg/mouse) and the surface area (50.3 vs. 25.7 mm2/mouse) of lesions decreased by approximately 50% of controls. To evaluate the proliferative activity of lesions, the ratio of Ki67-stained cells was calculated. In endometrial glands epithelia, the percentage of Ki67-positive cells decreased after parthenolide treatment (17.8 vs. 8.5%).

6.3. The role of the inhibitors of apoptosis proteins (IAPs) inhibitor as a new treatment

IAPs are a family of proteins implicated in multiple ways in cell death regulation, ranging from the inhibition of apoptosis to the regulation of cell cycle and inflammation. In the signaling pathway of apoptosis, IAPs have emerged as modulators in a step that involves direct inhibition of the terminal effectors, caspase-3, and -7. We previously reported higher expression of four IAPs (cIAP-1, cIAP-2, XIAP and survivin) in endometriotic tissue and endometriotic stromal cells (ESCs) than in eutopic endometrial tissues and eutopic endometrial stromal cells and demonstrated that IAP antagonist (BV6) repressed ESCs proliferation through NF-κB pathway (52).

To investigate the role of IAPs in the development of murine endometriosis lesions, we established the homologous ovariectomized murine model by transplanting uterine tissue as previously described (30). Recipient mice were treated with a single intraperitoneal injection of BV6 (10 mg/kg) twice weekly. After the treatment with BV6 for 4 weeks, the total number (Veh: 5.0 ± 1.6 vs BV6: 2.5 ± 0.6: P < .01), the average weight (Veh: 73.3 ± 27.8 mg vs BV6: 25.5 ± 10.7 mg: P < .01), and the surface area (Veh: 43.3 ± 17.1 mm2 vs BV6: 20.4 ± 6.2 mm2: P < .01) of lesions per mouse were significantly less than in the vehicle group. BV6 also decreased the Vegf, Il-6, Ccl-2, and Lif mRNA expression in the murine endometriosis-like lesions compared with the vehicle group (P < .05). BV6 also repressed the inflammatory and angiogenic activity and phospho-p65 NF-κB expression in endometriosis-like lesions (53).


Convenient and reliable endometriosis animal models are needed to accelerate emerging therapeutic alternatives. According to the Sampson’s “implantation theory”, we established the syngeneic immunocompetent mice model. In this model, we and the other investigators provided crucial evidence of both the development of endometriosis-like lesion growth and donor tissue responsiveness. Recently, Pelch et al described a detailed method of a surgically-induced endometriosis mouse model by auto-transplantation of its uterine tissue (32).

The rodent endometriosis models using mice or rats are widely used in research, but they may have limitations and may not mimic all aspects of human pathophysiology. For example, in homologous rodent models, “healthy’” uterus is cut into fragments and transplanted into the peritoneum, whereas it has been suggested that the eutopic endometrium of women suffering from endometriosis may already be abnormal (2). Nude mice lacking an intact immune system are employed in the heterologous model, which cannot mimic the inflammatory response normally seen in human endometriotic lesion (36). Although heterologous rodent endometriosis models are responsive to drugs and manipulations that induce a hypoestrogenic state, such as ovariectomy, GnRH agonists, aromatase inhibitors, danazol, and selective estrogen receptor modulators, it may be difficult to analyze novel target families in which, for example, the murine ligand does not bind to the receptor of the human transplant.

Whereas cell-based in vitro experiments provide a framework for testing molecular mechanisms, eventually, confirming their role in disease causality in vivo can only be accomplished by a suitable animal model. For a disease as diverse as endometriosis, a single animal model would unlikely be sufficient to represent the entire diversity in etiology, pathogenesis, and pathology. Each model has design-related strengths and limitations. For example, a recently described disease model consists of introducing endometrial tissue via direct injection into the peritoneal cavity of immunocompetent mice without suturing (28,32,40). In mice, the injected tissue forms cyst-like endometriosis lesions; however, the injection method does not seem to work in rats because the tissue fails to attach to and invade the peritoneal cavity (64). Since all endometriosis lesions in each model attached to the peritoneum and/or mesothelium with or without suturing, evaluating attachment or invasion of lesions would be difficult. Furthermore, in regard to quantifying the injected endometrial fragments, this model may be insufficient to evaluate the endometriotic lesions precisely.

The rodent model is used extensively to study the etiology, pathology, and risk factors of endometriosis (9,19,35,40,65-70) as well as to explore novel therapeutics (30,31,71-77). In conclusion, this model provides an important tool to evaluate a therapeutic approach to the disease. It will help to better understand disease evolution in the living animal and permit faster and more accurate characterization of a drug’s effect on experimental endometriosis.

To explain the pathophysiology of endometriosis and observe the endometriosis dispersion as early as possible without sacrificing the mice, we generated endometriosis mice model using transgenic eluc mice (with specific endometriosis genetic expression such as VEGF). Using in vivo imaging system (IVIS), the endometriosis disease progression, cell trafficking, and gene expression patterns in living animals can be easily observed. The differences between GFP mice and eluc mice is the endometriotic like lesion can not be detected in a deep intra peritoneum in GFP mice. (19) First, it needs a confirmation whether this animal model would become a reliable endometriosis model and whether the efficacy of drugs would be possible to be observed using this model. Our future plan and hope are to develop instruments to detect endometriotic lesions without laparoscopic intervention.


The authors have no conflicts to disclose relative to this work.






inhibitor of apoptosis proteins


phosphate buffered saline


estradiol valerate




nuclear factor


selective estrogen receptor modulator


In vivo Imaging System


Prostaglandin-endoperoxide synthase-2


Platelet Endothelial cell adhesion molecule


Vascular Endothelial Growth Factor


Reverse Transcription Polymerase Chain Reaction


Chemokine (C-C motif) ligand 2


interleukin 6


messenger Ribo Nucleic Acid


Protein that in human in encoded by the Mk167 gene


an IAP antagonist


Green Fluorescent Protein


Enhanced green-emitting Luciferase


Gonadotrophin Releasing Hormone


Estrogen Receptor-Beta


Estrogen Receptor- alpha


ERβ over-expressed

Sampson John A Metastatic or Embolic Endometriosis, due to the Menstrual Dissemination of Endometrial Tissue into the Venous Circulation. Am J Pathol 3(2), 93-110 1927 43
GiudiceLinda C EndometriosisLee C Kao In: Lancet,200417891799DOI: 10.1016/S0140-6736(04)17403-5
Erin Greaves O.D.Hilary Critcley WAndrew Horne T. KPhilippa Saunders: Relevant human tissue resources and laboratory models for use in endometriosis research. Acta Obstet Gynecol Scand2017966644658DOI: 10.1111/aogs.13119 PMid:28233896 PMCid:PMC5485163
SimitsidellisIoannis ADouglas Gibson: Animal models of endometriosis: Replicating the aetiology and symptoms of the human disorder. Best Pract Res Clin Endocrinol Metab2018323257269DOI: 10.1016/j.beem.2018.03.004 PMid:29779580
BHareesh Nair BakerRobert AMichael Owston EscalonaRenee JEdward Dick LJohn VandeBerg JKlaus Nickisch: An efficient model of human endometriosis by induced unopposed estrogenicity in baboons. Oncotarget,20161085710869DOI: 10.18632/oncotarget.7516 PMid:26908459 PMCid:PMC4905444
MJulie Hastings and Asgerally T Fazleabas: A baboon model for endometriosis: Implications for fertility. Reprod Biol Endocrinol20064Suppl 1S7DOI: 10.1186/1477-7827-4-S1-S7 PMid:17118171 PMCid:PMC1775067
TAsgerally Fazleabas BrudneyAllison GuratesBilgin ChaiDaniel BulunSerdar A modified baboon model for endometriosis. In: Annals of the New York Academy of Sciences,2002308317DOI: 10.1111/j.1749-6632.2002.tb02791.x PMid:11949957
HarirchianP GashawI LipskindS. T BraundmeierA. G HastingsJ. M OlsonM. R FazleabasA. T Lesion kinetics in a non-human primate model of endometriosis. Hum Reprod,201223412351DOI: 10.1093/humrep/des196 PMid:22674203 PMCid:PMC3398680
SokalskaAnna AndersonMariaPia VillanuevaJesus OrtegaIsrael LKaylon Bruner-Tran GKevin Osteen JAntoni Duleba: Effects of simvastatin on retinoic acid system in primary human endometrial stromal cells and in a chimeric model of human endometriosis. J Clin Endocrinol Metab,2013463471DOI: 10.1210/jc.2012-3402 PMid:23337719 PMCid:PMC3590479
SHugh Taylor Alderman IIIMyles MThomas D'Hooghe Asgerally T. Fazleabas and Antoni J. Duleba: Effect of simvastatin on baboon endometriosis. Biol Reprod20179713238DOI: 10.1093/biolre/iox058 PMid:28637327 PMCid:PMC6248548
F. William MacKenzie W Harold Casey: Animal model of human disease: endometriosis in rhesus monkeys. Am J Pathol 1975
BRoger Scott WRichard LindeTe RLaurance Wharton: Further studies on experimental endometriosis. Am J Obstet Gynecol,195310821103DOI: 10.1016/S0002-9378(16)38618-5
YanDingmin LiuXishi GuoSun-Wei Nerve fibers and endometriotic lesions: partners in crime in inflicting pains in women with endometriosis. Eur J Obstet Gynecol Reprod Biol20172091424DOI: 10.1016/j.ejogrb.2016.06.017 PMid:27418559
LangoiDavid PavoneMary Ellen GuratesBilgin ChaiDaniel FazleabasAsgerally BulunSerdar E Aromatase inhibitor treatment limits progression of peritoneal endometriosis in baboons. Fertil Steril,2013656662DOI: 10.1016/j.fertnstert.2012.11.021 PMid:23257603 PMCid:PMC3746767
LebovicDan I MJason Mwenda CDaniel Chai SantiAlessandro XuXiao D'HoogheThomas Peroxisome proliferator-activated receptor-gamma- receptor ligand partially prevents the development of endometrial explants in baboons: A prospective, randomized, placebo-controlled study. Endocrinology201018461852DOI: 10.1210/en.2009-1076 PMid:20160135 PMCid:PMC2850226
YamanakaAkiyoshi KimuraFuminori TakebayashiAkie KitaNobuyaki TakahashiKentaro MurakamiTakashi Primate model research for endometriosis. Tohoku J Exp Med,20129599DOI: 10.1620/tjem.226.95 PMid:22245765
TanakaYukiko MoriTaisuke ItoFumitake KoshibaAkemi TakaokaOsamu KataokaHisashi MaedaEiko OkimuraHiroyuki MoriTakahide KitawakiJo Exacerbation of endometriosis due to regulatory t-cell dysfunction. J Clin Endocrinol Metab,201732063217DOI: 10.1210/jc.2017-00052 PMid:28575420
GuoSun-Wei DingDing LiuXishi Anti-platelet therapy is efficacious in treating endometriosis induced in mouse. Reprod Biomed Online,2016484499DOI: 10.1016/j.rbmo.2016.07.007 PMid:27519725
HirataTetsuya OsugaYutaka YoshinoOsamu HirotaYasushi HaradaMiyuki TakemuraYuri MorimotoChieko KogaKaori YanoTetsu TsutsumiOsamu TaketaniYuji Development of an experimental model of endometriosis using mice that ubiquitously express green fluorescent protein. Hum Reprod,200520922096DOI: 10.1093/humrep/dei012 PMid:15831509
MAudrey Cummings LJoan Metcalf Induction of endometriosis in mice: A new model sensitive to estrogen. Reprod Toxicol,1995233238DOI: 10.1016/0890-6238(95)00004-T
GrummerRuth SchwarzerFrauke BainezykKatja StumppHulger Hess RegidorPedro A SchindlerAdolf F WinterhagerElke Peritoneal endometriosis: validation of an in-vivo model. Hum Reprod,20017361743DOI: 10.1093/humrep/16.8.1736 PMid:11473975
RossiGabriele MoschettaEdgardo Somigliana Marta CozzolinoRoberta Santorsola Sabrina SalmasoPaola Filardo Alessandra ZingrilloBeatrice Dynamic aspects of endometriosis in a mouse model through analysis of implantation and progression. Arch Gynecol Obstet,2000102107DOI: 10.1007/s004040050005 PMid:10763836
YuanMing LiDong AnMin LiQiuju ZhangLu WangGuoyun Rediscovering peritoneal macrophages in a murine endometriosis model. Hum Reprod,201794102DOI: 10.1093/humrep/dew274 PMid:27816922
King Claire M Barbara Cynthia Prentice Andrew Brenton James D Charnock-Jones D Stephen Models of endometriosis and their utility in studying progression to ovarian clear cell carcinoma. J Pathol, 2016
HernandezSiomara CruzMyrella L SeguinotInevy I Torres-ReveronAnnelyn AppleyardCaroline B Impact of Psychological Stress on Pain Perception in an Animal Model of Endometriosis. Reprod Sci,201713711381DOI: 10.1177/1933719116687655 PMid:28093054 PMCid:PMC5933089
LiuShuangge XinXiaoyan HuaTeng ShiRui ChiShuqi JinZhishan WangHongbo Efficacy of anti-VEGF/VEGFR agents on animal models of endometriosis: A systematic review and meta-analysis. PLoS One 11, (11),2016115DOI: 10.1371/journal.pone.0166658 PMid:27855197 PMCid:PMC5113963
DoddsKelsi N BeckettElizabeth A. H EvansSusan F HutchinsonMark R Lesion development is modulated by the natural estrous cycle and mouse strain in a minimally invasive model of endometriosis. Biol Reprod,2017810821DOI: 10.1093/biolre/iox132 PMid:29069288
JSilva ASilva FReis SGarcia M ANogueira Development of an experimental model of endometriosis in rabbits. Int Congr Ser 1271(C),2004248251DOI: 10.1016/j.ics.2004.05.092
W Song H Lu W Hou G Xu J Zhang Y Sheng M Cheng R Zhang Expression of vascular endothelial growth factor C and anti-angiogenesis therapy in endometriosis. Int J Clin Exp Pathol 7, (11), 2014 7752 7759
TakaiEri TaniguchiFuminori NakamuraKazuomi UegakiTakashi IwabeTomio HaradaTasuku Parthenolide reduces cell proliferation and prostaglandin estradiol synthesis in human endometriotic stromal cells and inhibits development of endometriosis in the murine model. Fertil Steril 100, (4),201311701178DOI: 10.1016/j.fertnstert.2013.06.028 PMid:23876538
KulakJaime FischerCatha KommBarry SHugh Taylor Treatment with bazedoxifene, a selective estrogen receptor modulator, causes regression of endometriosis in a mouse model. Endocrinology,201132263232DOI: 10.1210/en.2010-1010 PMid:21586552 PMCid:PMC3138238
Pelch Katherine E Sharpe-Timms Kathy L Nagel Susan C Mouse model of surgically-induced endometriosis by auto-transplantation of uterine tissue. J Vis Exp, 2012 1 8
PeterseDaniëlle P FassbenderAmelie ODorien F VanhieArne SaundersPhilippa VriensJoris BindaM. Mercedes SurgeryThomas M. D'Hooghe: Laparoscopic A New Technique to Induce Endometriosis in a Mouse Model. Reprod Sci,201613321339DOI: 10.1177/1933719116638178 PMid:26994066
PeterseDaniëlle BindaM. Mercedes ODorien F VanhieArne FassbenderAmelie VriensJoris MThomas D'Hooghe Of Mice and Women: A Laparoscopic Mouse Model for Endometriosis. J Minim Invasive Gynecol,2018578579DOI: 10.1016/j.jmig.2017.10.008 PMid:29032250
StoryLisa KennedyStephen Animal studies in endometriosis: a review. ILAR J 45, (2)2004132138DOI: 10.1093/ilar.45.2.132 PMid:15111732
Tirado-GonzálezIrene BarrientosGabriela TariverdianNadja ArckPetra C GarcíaMariana G KlappBurghard F MBloisSandra Endometriosis research: Animal models for the study of a complex disease. J Reprod Immunol,2010141147DOI: 10.1016/j.jri.2010.05.001 PMid:20594597
LeeBanghyun DuHongling TaylorHugh S Experimental Murine Endometriosis Induces DNA Methylation and Altered Gene Expression in Eutopic Endometrium 1. Biol Reprod,20097985DOI: 10.1095/biolreprod.108.070391 PMid:18799756 PMCid:PMC2804809
-TranKaylon L. Bruner EisenbergEsther YeamanGrant R AndersonTed A BeanJudith MC OsteenKevin G Steroid and cytokine regulation of matrix metalloproteinase expression in endometriosis and the establishment of experimental endometriosis in nude mice. J Clin Endocrinol Metab,200247824791DOI: 10.1210/jc.2002-020418 PMid:12364474
StyerAaron K SullivanBrian T PuderMark ArsenaultDanielle PetrozzaJohn C SerikawaTakehiro ChangSung HasanTayyaba GonzalezRuben R RuedaBo R Ablation of leptin signaling disrupts the establishment, development, and maintenance of endometriosis-like lesions in a murine model. Endocrinology,2008506514DOI: 10.1210/en.2007-1225 PMid:17962343 PMCid:PMC2219296
BurnsKatherine A RodriguezKarina F HewittSylvia C JanardhanKyathanahalli S YoungSteven L KorachKenneth S Role of estrogen receptor signaling required for endometriosis-like lesion establishment in a mouse model. Endocrinology,201239603971DOI: 10.1210/en.2012-1294 PMid:22700766 PMCid:PMC3404357
GuoSun-Wei DingDing GengJian-Guo WangLijing LiuXishi P-selectin as a potential therapeutic target for endometriosis. Fertil Steril, 990-10002015e8DOI: 10.1016/j.fertnstert.2015.01.001 PMid:25681855
AttamanJill A StanicAleksandar K KimMinji LynchMaureen P RuedaBo R StyerAaron K The anti-inflammatory impact of omega-3 polyunsaturated fatty acids during the establishment of endometriosis-like lesions. Am J Reprod Immunol,2014392402DOI: 10.1111/aji.12276 PMid:24898804
LiuJun-Wei CaiMin-Xia XinYing WuQing-Song MaJun YangPo XieHai-Yang HuangDong-Sheng Parthenolide induces proliferation inhibition and apoptosis of pancreatic cancer cells in vitro. J Exp Clin Cancer Res,2010108DOI: 10.1186/1756-9966-29-108 PMid:20698986 PMCid:PMC2924280
HaradaTasuku IwabeTomio TerakawaNaoki Role of cytokines in endometriosis. Fertil Steril,2001110DOI: 10.1016/S0015-0282(01)01816-7
KhanKhaleque Newaz KitajimaMichio HirakiKoichi YamaguchiNaohiro KatamineShigeru MatsuyamaToshifumi NakashimaMasahiro FujishitaAkira IshimaruTadayuki MasuzakiHideaki Escherichia coli contamination of menstrual blood and effect of bacterial endotoxin on endometriosis. Fertil Steril,201028602863DOI: 10.1016/j.fertnstert.2010.04.053 PMid:20627244
KhanKhaleque Newaz KitajimaMichio InoueTsuneo FujishitaAkira NakashimaMasahiro MasuzakiHideaki 17 Beta-estradiol and lipopolysaccharide additively promote pelvic inflammation and growth of endometriosis. Reprod Sci,2015585594DOI: 10.1177/1933719114556487 PMid:25355803 PMCid:PMC4519769
Azuma Yukihiro Taniguchi Fuminori Nakamura Kazuomi Nagira Kei Khine Yin Mon Kiyama Tomoiki Uegaki Takashi Izawa Masao Harada Tasuku Lipopolysaccharide promotes the development of murine endometriosis-like lesions via the nuclear factor-kappa B pathway. Am J Reprod Immunol 2017
Khine Yin Mon Taniguchi Fuminori Nagira Kei Nakamura Kazuomi Ohbayashi Tetsuya Osaki Mitsuhiko Harada Tasuku New insights into the efficacy of SR-16234, a selective estrogen receptor modulator, on the growth of murine endometriosis-like lesions. Am J Reprod Immunol 2018
JainNaveen K KulkarniShrinivas K Antinociceptive and anti-inflammatory effects of Tanacetum parthenium L. extract in mice and rats. J Ethnopharmacol,1999251259DOI: 10.1016/S0378-8741(99)00115-4
GuzmanMonica L RossiRandall M KarnischkyLilliana LiXiaojie PetersonDerick R HowardDianna S JordanCraig T The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells. Blood,200541634169DOI: 10.1182/blood-2004-10-4135 PMid:15687234 PMCid:PMC1895029
JChristopher Sweeney Mehrotra1 Sanjana RMiral Sadaria KumarSuresh HNicholas Shortle RomanYaritzabel SheridanCarol ARobert Campbell JDaryl Murry BadveSunil NakshatriHarikrishna The sesquiterpene lactone parthenolide in combination with docetaxel reduces metastasis and improves survival in a xenograft model of breast cancer. Mol Cancer Ther,200510041012DOI: 10.1158/1535-7163. MCT-05-0030 PMid:15956258
TaniguchiFuminori HigakiHiroko IzawaMasao AzumaYukihiro HirakawaEriko DeuraImari IwabeTomio HataKohkichi HaradaTasuku The cellular inhibitor of apoptosis protein-2 is a possible target of novel treatment for endometriosis. Am J Reprod Immunol2014713278285DOI: 10.1111/aji.12193 PMid:24382102
TaniguchiFuminori UegakiTakashi NakamuraKazuomi MonKhine Yin HaradaTakashi OhbayashiTetsuya HaradaTasuku Inhibition of IAP (inhibitor of apoptosis) proteins represses inflammatory status via nuclear factor-kappa B pathway in murine endometriosis lesions. Am J Reprod Immunol,201879DOI: 10.1111/aji.12780 PMid:29105884
MAudrey Cummings HedgeJoan M BimbaumLinda S Effect of prenatal exposure to TCDD on the promotion of endometriotic lesion growth by TCDD in adult female rats and mice. Toxicol Sci,19994549DOI: 10.1093/toxsci/52.1.45 PMid:10568697
PShawn Murphy TayadeChandrakant AAli Ashkar HattaKota ZhangJianhong CroyB. Anne Interferon Gamma in Successful Pregnancies 1. Biol Reprod2009805848859DOI: 10.1095/biolreprod.108.073353 PMid:19164174 PMCid:PMC2849832
SeawardA. V. C BurkeS. D CroyB. A Interferon gamma contributes to preimplantation embryonic development and to implantation site structure in NOD mice. Hum Reprod,20108292839DOI: 10.1093/humrep/deq236 PMid:20813805 PMCid:PMC2957476
KingAnne E ChritcleyHillary O. D KellyRodney W The NF-kappaB pathway in human endometrium and first trimester decidua. Mol Hum Reprod,2001175183DOI: 10.1093/molehr/7.2.175 PMid:11160844
HanSang Jun HawkinsShannon M BegumKhurshida JungSung Yun KovanciErtug QinJun LydonJohn P MayoFrancesco J De O'MalleyBert W A new isoform of steroid receptor coactivator-1 is crucial for pathogenic progression of endometriosis. Nat Med,201211021111DOI: 10.1038/nm.2826 PMid:22660634 PMCid:PMC3541027
WieserFriedrich JuanjuanWu ShenZhaoju TaylorRobert N SidellNeil Retinoic acid suppresses growth of lesions, inhibits peritoneal cytokine secretion, and promotes macrophage differentiation in an immunocompetent mouse model of endometriosis. Fertil Steril,201214301437DOI: 10.1016/j.fertnstert.2012.03.004 PMid:22464761 PMCid:PMC3367060
NakamuraHitomi KimuraTadashi OgitaKazuhide NakamuraTakafumi TakemuraMasahiko ShimoyaKoichiro KoyamaSinsuke TsujieTomoko KoyamaMasayasu MurataYuji NF-kappa Beta activation at implantation window of the mouse uterus. Am J Reprod Immunol,20041621DOI: 10.1046/j.8755-8920.2003.00116.x PMid:14725562
YanDingmin LiuXishi GuoSun-Wei The establishment of a mouse model of deep endometriosis. Hum Reprod 34, (2),2019235247DOI: 10.1093/humrep/dey361 PMid:30561644
Han Sang Jun Lee Jiyeun E Cho Yeon Jean Park Mi Jin O'Malley Bert W Genomic Function of Estrogen Receptor β in Endometriosis. Endocrinology, 2019 495 2516
Sharpe-TimmsK. L Piva2 M RickeE. A SurewiczK ZhangY. L ZimmerR. L Endometriotic Lesions Synthesize and Secrete a Haptoglobin-Like Protein 1. Biol Reprod,1998988994DOI: 10.1095/biolreprod58.4.988 PMid:9546730
Vernon Michael W Emery A. Wilson: Studies on the surgical induction of endometriosis in the rat. Fertil Steril, 1985 684 694
LuYuan NieJichan LiuXishi ZhengYu GuoSun-Wei Trichostatin A, a histone deacetylase inhibitor, reduces lesion growth and hyperalgesia in experimentally induced endometriosis in mice. Hum Reprod,201010141025DOI: 10.1093/humrep/dep472 PMid:20118114
YavuzEmrah OktemMesut EsinlerIbrahim ZeynelogluHulusi B Genistein causes regression of endometriotic implants in the rat model. Fertil Steril,200711291134DOI: 10.1016/j.fertnstert.2007.01.010 PMid:17559846
DmitrievaNatalia NagabukuroHiroshi ResuehrDavid ZhangGuohua McAllisterStacy McGintyKristina MackieKen BerkleyKaren Endocannabinoid involvement in endometriosis. Pain,2010703710DOI: 10.1016/j.pain.2010.08.037 PMid:20833475 PMCid:PMC2972363
EfstathiouJason A ADavid A. SampsonB LevineZalman RohanRichard M ZurakowskiDavid FolkmanJudah D'AmatoRobert J RupnickMaria A Nonsteroidal antiinflammatory drugs differentially suppress endometriosis in a murine model. Fertil Steril,20051711DOI: 10.1016/j.fertnstert.2004.06.058 PMid:15652904
BeckerChristian M ADavid A. SampsonB ShortSarah M JavaherianKashi FolkmanJudah D'AmatoRobert J Short synthetic endostatin peptides inhibit endothelial migration in vitro and endometriosis in a mouse model. Fertil Steril,20067177DOI: 10.1016/j.fertnstert.2005.07.1290 PMid:16412733
Rudzitis-AuthJ Menger LaschkeM. W Resveratrol is a potent inhibitor of vascularization and cell proliferation in experimental endometriosis. Hum Reprod,201313391347DOI: 10.1093/humrep/det031 PMid:23427233
Novella-MaestreEdurne HerraizSonia Vila-VivesJosé María CardaCarmen Ruiz-SauriAmparo PellicerAntonio Effect of antiangiogenic treatment on peritoneal endometriosis-associated nerve fibers. Fertil Steril,201212091217DOI: 10.1016/j.fertnstert.2012.07.1103 PMid:22921078
MMariani PVigan DGentilini BCamisa ECaporizzo PDi Lucia AMonno MCandiani ESomigliana PPanina-Bordignon The selective vitamin D receptor agonist, elocalcitol, reduces endometriosis development in a mouse model by inhibiting peritoneal inflammation. Hum Reprod,201220102019DOI: 10.1093/humrep/des150 PMid:22588001
CakmakHakan BasarMurat Seval-CelikYasemin OsteenKevin G DulebaAntoni J TaylorHugh S LockwoodCharles J AriciAydin Statins inhibit monocyte chemotactic protein 1 expression in endometriosis. Reprod Sci,2012572579DOI: 10.1177/1933719111430998 PMid:22267540 PMCid:PMC3439122
LeconteMahaut NiccoCarole NgôCharlotte ChéreauChristiane ChouzenouxSandrine MarutWioleta GuibourdencheJean ArkwrightSylviane WeillBernard ChapronCharles DoussetBertrand BatteuxFrédéric The mTOR/AKT inhibitor temsirolimus prevents deep infiltrating endometriosis in mice. Am J Pathol 179, (2),2011880889DOI: 10.1016/j.ajpath.2011.04.020 PMid:21718677 PMCid:PMC3157265
OlivaresCarla RicciAnalía BilotasMariela InésBarañaoRosa MeresmanGabriela The inhibitory effect of celecoxib and rosiglitazone on experimental endometriosis. Fertil Steril,2011428433DOI: 10.1016/j.fertnstert.2011.05.063 PMid:21683949
PerellóMaria González-ForuriaIñaki CastilloPaola Martínez-FlorensaMario LozanoFrancisco BalaschJuan CarmonaFrancisco Oral Administration of Pentoxifylline Reduces Endometriosis-Like Lesions in a Nude Mouse Model. Reprod Sci,2017911918DOI: 10.1177/1933719116673198 PMid:27738175
WangNingning HongShanshan TanJinfeng KePeiqi LiangLili FeiHui LiuBin LiuLiqun LiuYongdong YuBingjun A red fluorescent nude mouse model of human endometriosis: Advantages of a non-invasive imaging method. Eur J Obstet Gynecol Reprod Biol 176, (1),20142530DOI: 10.1016/j.ejogrb.2014.02.012 PMid:24630298
TalAya TalReshef PluchinoNicola TaylorHugh S Endometrial cells contribute to preexisting endometriosis lesions in a mouse model of retrograde menstruation. Biol Reprod,201914531460DOI: 10.1093/biolre/ioz039 PMid:30869747 PMCid:PMC6561859
DaftaryGaurang S ZhengYe TabbaaZaid M SchoolmeesterJohn K GadaRavi P GrzendaAdrienne L MathisonAngela J KeeneyGary L LomberkGwen A UrrutiaRaul A Novel Role of the Sp/KLF Transcription Factor KLF11 in Arresting Progression of Endometriosis. PLoS One 8, (3),2013110DOI: 10.1371/journal.pone.0060165 PMid:23555910 PMCid:PMC3610699
Publisher’s Note: IMR Press stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Back to top